Studying genes and the development of cardiac hypertrophy: Convenient intermediate phenotypes in man

Journal of Hypertension

Volumn 21, Issue 5, 2003, Pages 873-874

  Fraser, Robert ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; CELL GROWTH; DISEASE COURSE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DIFFERENCE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VITRO STUDY; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PUBLICATION;

EID: 0038652092     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200305000-00010     Document Type: Note

References (19)

1. Deschepper CF, Boutin-Ganache I, Zahabi A, Jiang Z. In search of cardiovascular genes. Interactions between phentypes and genotypes. Hypertension 2002; 39:332-336.
2. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med 1992; 120:893-901.
3. Barbato JC, Mulrow PJ, Shapiro JI, Franco-Saenz R. Rapid effects of aldosterone and spironolactone in the isolated working rat heart. Hypertension 2002; 40:130-135.
4. Satoh M, Nakamura M, Saitoh H, Satoh H, Akatsu T, Iwasaka J, et al. Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clin Sci 2002; 102:381-386.
5. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998; 273:4883-4891.
6. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H. Cardiac aldosterone production in genetically hypertensive rats. Hypertension 2000; 36:495-500.
7. Young MJ, Clyne CD, Cole TJ, Funder JW. Cardiac steroidogenesis in the normal and failing heart. J Clin Endocrinol Metab 2001; 86:5121-5126.
8. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, et al. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103:72-77.
9. Cusi D, Bianchi G. A primer on the genetics of hypertension Kidney Int 1998; 54:328-342.
10. Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, McBride MW, Alexander MY. Genes and hypertension. From gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000; 35:164-172.
11. Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G, Sega R. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control. Data from the PAMELA population. Hypertension 2002; 39:744-749.
12. Boheler KR, Schwartz K. Gene expression in cardiac hypertrophy. Trends Cardiovasc Med 1992; 2:176-182.
13. Garner C, Lecomte E, Visvikis S, Abergel E, Lathrop M, Soubrier F. Genetic and environmental influences on left ventricular mass. A family study. Hypertension 2000; 36:740-746.
14. Davidson AO, Schork N, Jaques BC, Kelman AW, Sutcliffe RG, Reid JL, Dominiczak AF. Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. Hypertension 1995; 26:452-459.
15. Cooper G. Basic determinants of myocardial hypertrophy. Ann Rev Med 1997; 48:13-23.
16. Myerson SG, Bellenger NG, Pennell DJ. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 2002; 39:750-755.
17. Robert V, Silvestre J-S, Charlemagne D, Sabri A, Trouve P, Wassef M, et al. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 1995; 26:971-978.
18. Takahashi T, Ueno H, Yasumoto K, Kagitani S, Tomoda F, Inoue H, Takata M. ACE-gene polymorphism is associated with collagen I synthesis and QT dispersion in essential hypertension. J Hypertens 2003; 21:985-990.
19. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation 1995; 91:1450-1456.